Scaling Synthetic Biology (with Ginkgo’s Reshma Shetty)
Azeem Azhar's Exponential View
00:00
Are You Taking a Venture Capital Approach?
Riht works with many different companies across a lot of different spaces and diffrent applications. We're not naive enough to believe that every single one of our cell programmes will ultimately be commercially successful. But the bet we're making is that enough of them will to justify the entire enterprise. The way we manage those risks is like venture capitalists with a portfolio approach.
Transcript
Play full episode
